Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1549230 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,459,441
+$2,996,594 QoQ
Shares Held
27,382
+724.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#675
of 2,266 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2023
CallValue
$11,375,532
CallShares
147,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $33,506,104 across 12 Drug Manufacturers - General names. GILD ranks #5 (10.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GILD
Gilead Sciences, Inc.
This page
27,382 $3,459,441

All Filings in GILD

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,459,441 27,382
2026-03-31 $462,847 3,321
2025-09-30 $246,420 2,220
2025-06-30 $219,411 1,979
2023-06-30 $11,375,532 147,600
2023-03-31 $12,180,576 146,807
2022-12-31 $6,081,184 70,835
2022-09-30 $228,253 3,700
2022-09-30 $240,591 3,900
2022-06-30 $307,999 4,983
2022-03-31 $1,646,765 27,700
2022-03-31 $1,688,380 28,400
2021-09-30 $432,371 6,190
2021-06-30 $592,196 8,600
2021-06-30 $432,922 6,287
2021-03-31 $933,838 14,449
2020-12-31 $452,971 7,775
2020-03-31 $964,404 12,900